These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 4818170

  • 21. Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
    Aguado JM, Lumbreras C, González-Vidal D, Grupo de Farmacovigilancia de Abelcet.
    Clin Microbiol Infect; 2004 Sep; 10(9):785-90. PubMed ID: 15355408
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical correlations during amphotericin B therapy.
    Goodpasture HC, Voth DW, Romig DA, Cheng D, Wenglin BD, Liu C.
    J Kans Med Soc; 1972 Nov; 78(11):486-90. PubMed ID: 5078570
    [No Abstract] [Full Text] [Related]

  • 24. [Advances in research on reducing toxicity of amphotericin B].
    Xu XQ.
    Zhonghua Nei Ke Za Zhi; 1989 Apr; 28(4):243-5. PubMed ID: 2680337
    [No Abstract] [Full Text] [Related]

  • 25. Nephrotoxicity of different formulations of amphotericin B: summarizing evidence by network meta-analysis.
    Messori A, Fadda V, Maratea D, Trippoli S, Marinai C.
    Clin Infect Dis; 2013 Dec; 57(12):1783-4. PubMed ID: 24140972
    [No Abstract] [Full Text] [Related]

  • 26. Minimizing nephrotoxicity using continuous infusion of deoxycholate amphotericin B.
    Gwee A, Cranswick N, Connell TG, Curtis N.
    Pediatr Infect Dis J; 2014 Oct; 33(10):1098. PubMed ID: 25361191
    [No Abstract] [Full Text] [Related]

  • 27. Liposomal amphotericin B for fever and neutropenia.
    Patel MA, Curtis K, Maguire JH.
    N Engl J Med; 1999 Oct 07; 341(15):1153; author reply 1154-5. PubMed ID: 10515752
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Reply to Messori et al.
    Mistro S, Schooley RT, Badaro R.
    Clin Infect Dis; 2013 Dec 07; 57(12):1784-5. PubMed ID: 24140973
    [No Abstract] [Full Text] [Related]

  • 33. Does lipid emulsion reduce amphotericin B nephrotoxicity? A systematic review and meta-analysis.
    Mistro S, Maciel Ide M, de Menezes RG, Maia ZP, Schooley RT, Badaró R.
    Clin Infect Dis; 2012 Jun 07; 54(12):1774-7. PubMed ID: 22491505
    [Abstract] [Full Text] [Related]

  • 34. Impact of the administration of liposomal amphotericin B in patients with renal function impairment at initiation of treatment.
    Alvarez-Lerma F, Mariscal F, Quintana E, Rialp G, Diaz-Reganon J, Pérez San José MJ, Alvarez-Sanchez B, Liposomal Amphotericin B in the ICU Study Group.
    J Chemother; 2010 Aug 07; 22(4):285-7. PubMed ID: 20685637
    [No Abstract] [Full Text] [Related]

  • 35. Lipid formulations of amphotericin B preserve and stabilize renal function in HSCT recipients.
    Miller CB, Waller EK, Klingemann HG, Dignani MC, Anaissie EJ, Cagnoni PJ, McSweeney P, Fleck PR, Fruchtman SM, McGuirk J, Chao NJ.
    Bone Marrow Transplant; 2004 Mar 07; 33(5):543-8. PubMed ID: 14730342
    [Abstract] [Full Text] [Related]

  • 36. Lipid formulations of amphotericin B.
    Dix SP, Andriole VT.
    Curr Clin Top Infect Dis; 2000 Mar 07; 20():1-23. PubMed ID: 10943516
    [Abstract] [Full Text] [Related]

  • 37. Rapid infusion of amphotericin B: is it safe, effective, and wise?
    Schuler U, Ehninger G.
    Am J Med; 1995 Jul 07; 99(1):104-5. PubMed ID: 7598128
    [No Abstract] [Full Text] [Related]

  • 38. New approach to therapy with amphotericin B.
    Drutz DJ, Spickard A, Koenig MG.
    Antimicrob Agents Chemother (Bethesda); 1966 Jul 07; 6():202-7. PubMed ID: 5985245
    [No Abstract] [Full Text] [Related]

  • 39. [Treatment and prevention of generalized mycoses].
    van der Spoel JI.
    Ned Tijdschr Geneeskd; 1995 Oct 21; 139(42):2164-5. PubMed ID: 7477586
    [No Abstract] [Full Text] [Related]

  • 40. Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis.
    Yamazaki H, Kondo T, Aoki K, Yamashita K, Takaori-Kondo A.
    Diagn Microbiol Infect Dis; 2018 Feb 21; 90(2):123-131. PubMed ID: 29203252
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.